SRSF2 and chronic myelomonocytic leukemia: These findings are consistent with GO analyses in SRSF2-mutant cells from primary MDS (9), CMML (Figure 6B) (7), and AML patients (Figure 6B) (7, 32), which similarly showed enrichment of mitochondrial genes in the set of alternatively spliced mRNAs.